- Open Access
Erratum to: COPPADIS-2015 (COhort of Patients with PArkinson’s DIsease in Spain, 2015), a global –clinical evaluations, serum biomarkers, genetic studies and neuroimaging– prospective, multicenter, non-interventional, long-term study on Parkinson’s disease progression
BMC Neurologyvolume 16, Article number: 44 (2016)
The original article was published in BMC Neurology 2016 16:26
After publication of the original article , it has come to the authors’ attention that there were a number of errors in the manuscript which were not identified at proofing. These errors affect the affiliations, Table 2, and the COPPADIS study group collaborators listed in the Acknowledgements section.
In the author list, J. Infante should have been affiliated with institutions 3 and 9, rather than just 9, as appears correctly in the author list of this erratum.
There were a number of errors in Table 2, involving the names of institutions listed in column 1. Minor errors were present in institutions 25 (Hospital da Costa, Burela), and 39 (Centro Neurológico OMS 42) within the table. In addition, the ‘Complementary studies’ column of institution 38 (Hospital Josep Trueta and Parc Martí i Juliá) should have read ‘15/10’. As a result, the row of totals found at the bottom of Table 2 was incorrect for this column, and should have read ‘315/110’.
Table 2 appears correctly in this erratum.
Finally, there were errors in the COPPADIS Study group (collaborators) section. The sentence “Finally, this author will not participate in the study” was mistakenly included between the names of Ferriol MM and Leiva C. In addition, the collaborator Clemente J should have appeared as ‘Segundo JC’.
Within the affiliations of this section, the city names of institutions 19 (Hospital Clínico San Carlos, Madrid) and 20 (Hospital da Costa, Burela, Lugo) appear incorrectly.
Santos-García D, Mir P, Cubo E, Vela L, Rodríguez-Oroz MC, Martí MJ, et al. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global -clinical evaluations, serum biomarkers, genetic studies and neuroimaging- prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression. BMC Neurol. 16;26. doi:10.1186/s12883-016-0548-9.
The online version of the original article can be found under doi:10.1186/s12883-016-0548-9.